Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|November 2, 2011
Supplements and Featured Publications
- Improving Outcomes in Chronic Kidney Disease: Optimizing Management of Cardiovascular Diseases [CME/
- Volume 17
- Issue 15 Suppl
Improving Outcomes in Chronic Kidney Disease: Optimizing Management of Cardiovascular Diseases
Advertisement
Instructions
After reading “Improving Outcomes in Chronic Kidney Disease: Optimizing Management of Cardiovascular Diseases,” complete the program evaluation and select the 1 best answer to each of the posttest questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.
Articles in this issue
Advertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Advertisement
Advertisement
Trending on AJMC
1
How Plans, Clinicians Should Handle Gray-Market Retatrutide
2
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
3
IVF Beats IUI for Early Live Births in Unexplained Infertility
4
Early-Onset Cancers Often Found Late as Screening Gaps Persist
5